FDA approval of EKTERLY makes KalVista Pharmaceuticals, Inc. the first to offer an oral on-demand HAE therapy. Click here to find out why KALV is a Strong Buy.

Humacyte (HUMA) stock rises as Symvess gains ECAT listing, enhancing its access at military healthcare facilities. Read more ...

Pre-approved garden suite plans The City offers pre-approved plans for one-bedroom and studio garden suites, making it easier for homeowners to build a detached unit on their property. Garden suites ...